CHARYN TAB 500 MG CAJA C/3 ASPEN LABS Mesotelioma maligno pleural en pacientes

Description

Mesotelioma maligno pleural en pacientes adultos

COFEPRIS: 0119M80 SSA VI

PRINCIPIO ACTIVO: CANAGLIFLOZINA

Hipersensibilidad a alguno de los componentes de la fórmula

Contiene 50 mcg de Mircera por jeringa

CHARYN TAB 500 MG CAJA C/3 ASPEN LABS Mesotelioma maligno pleural en pacientesSUSTANCIA: CHARYN TAB. 500 MG. CAJA C 3 FABRICANTE: WERMAR

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy